Clinical Trial Results:
A Randomized, Double-blind, Double-dummy, Placebo-controlled,
Multicentre, 6-way Crossover, Single-dose, Phase IIa study to Evaluate the
Pharmacokinetics and Pharmacodynamics of different Dry Powder
Inhalation Formulations of AZD3199 Administered via Single Inhalation
Device compared to AZD3199 Administered via Turbuhaler® inhaler in
Patients with Asthma
Summary
|
|
EudraCT number |
2011-000133-37 |
Trial protocol |
SE |
Global completion date |
27 Feb 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
27 Oct 2016
|
First version publication date |
27 Oct 2016
|
Other versions |
|
Summary report(s) |
D0570C00011_CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.